Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Anavex Life Sciences, Appili, Astellas, Astrazeneca, Atea, Beigene, Calcimedica, Daiichi Sankyo, Fibrogen, Genexine, I-Mab Biopharma, Octapharma USA, Organicell Regenerative Medicine.